162 related articles for article (PubMed ID: 36851760)
1. Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children.
Fofana DB; Diarra H; Guindo I; Savadogo MK; d'Almeida M; Diallo FI; Baldé A; Soulié C; Kone A; Marcelin AG; Maiga AI; Lambert-Niclot S; Maiga M; McFall S; Hawkins CA; Murphy RL; Sylla M; Katlama C; Holl JL; Calvez V; Morand-Joubert L
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851760
[TBL] [Abstract][Full Text] [Related]
2. Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.
Lataillade M; Chiarella J; Kozal MJ
Antivir Ther; 2007; 12(4):563-70. PubMed ID: 17668566
[TBL] [Abstract][Full Text] [Related]
3. Short communication: analysis of the integrase gene from HIV type 1-positive patients living in a rural area of West Cameroon.
Turriziani O; Montagna C; Falasca F; Bucci M; Russo G; Lichtner M; Sobze MS; Vullo V; Pistello M; Antonelli G
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1729-33. PubMed ID: 22214532
[TBL] [Abstract][Full Text] [Related]
4. Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.
Garrido C; Geretti AM; Zahonero N; Booth C; Strang A; Soriano V; De Mendoza C
J Antimicrob Chemother; 2010 Feb; 65(2):320-6. PubMed ID: 20007331
[TBL] [Abstract][Full Text] [Related]
5. HIV type 1 integrase polymorphisms in treatment-naive and treatment-experienced HIV type 1-infected patients in Thailand where HIV type 1 subtype A/E predominates.
Phuphuakrat A; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):937-43. PubMed ID: 21970343
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland.
Parczewski M; Bander D; Urbańska A; Boroń-Kaczmarska A
BMC Infect Dis; 2012 Dec; 12():368. PubMed ID: 23259737
[TBL] [Abstract][Full Text] [Related]
7. Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy.
Acharya A; Tagny CT; Mbanya D; Fonsah JY; Nchindap E; Kenmogne L; Jihyun M; Njamnshi AK; Kanmogne GD
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106437
[No Abstract] [Full Text] [Related]
8. Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia.
Avi R; Huik K; Sadam M; Karki T; Krispin T; Ainsalu K; Paap P; Schmidt J; Nikitina N; Lutsar I
AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1109-13. PubMed ID: 20849300
[TBL] [Abstract][Full Text] [Related]
9. HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.
Gottlieb GS; Smith RA; Dia Badiane NM; Ba S; Hawes SE; Toure M; Starling AK; Traore F; Sall F; Cherne SL; Stern J; Wong KG; Lu P; Kim M; Raugi DN; Lam A; Mullins JI; Kiviat NB;
PLoS One; 2011; 6(7):e22204. PubMed ID: 21765953
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
Charpentier C; Malet I; Andre-Garnier E; Storto A; Bocket L; Amiel C; Morand-Joubert L; Tumiotto C; Nguyen T; Maillard A; Rodallec A; Leoz M; Montes B; Schneider V; Plantier JC; Dina J; Pallier C; Mirand A; Roussel C; Signori-Schmuck A; Raymond S; Calvez V; Delaugerre C; Marcelin AG; Descamps D
J Antimicrob Chemother; 2018 Apr; 73(4):1039-1044. PubMed ID: 29342281
[TBL] [Abstract][Full Text] [Related]
11. Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals.
Llácer Delicado T; Torrecilla E; Holguín Á
J Antimicrob Chemother; 2016 Feb; 71(2):362-6. PubMed ID: 26546669
[TBL] [Abstract][Full Text] [Related]
12. Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study.
Nouhin J; Donchai T; Hoang KT; Ken S; Kamkorn J; Tran T; Ayouba A; Peeters M; Chaix ML; Lien TX; Nerrienet E; Ngo-Giang-Huong N
Infect Genet Evol; 2011 Jan; 11(1):38-43. PubMed ID: 21094281
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment.
El Bouzidi K; Kemp SA; Datir RP; Murtala-Ibrahim F; Aliyu A; Kwaghe V; Frampton D; Roy S; Breuer J; Sabin CA; Ogbanufe O; Charurat ME; Bonsall D; Golubchik T; Fraser C; Dakum P; Ndembi N; Gupta RK
J Antimicrob Chemother; 2020 Jun; 75(6):1575-1579. PubMed ID: 32105319
[TBL] [Abstract][Full Text] [Related]
14. Analyses of HIV-1 integrase gene sequences among treatment-naive patients in the Eastern Cape, South Africa.
Onoriode Digban T; Chucks Iweriebor B; Chikwelu Obi L; Nwodo U; Ifeanyi Okoh A
J Med Virol; 2020 Aug; 92(8):1165-1172. PubMed ID: 31889319
[TBL] [Abstract][Full Text] [Related]
15. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
Brenner BG; Lowe M; Moisi D; Hardy I; Gagnon S; Charest H; Baril JG; Wainberg MA; Roger M
J Med Virol; 2011 May; 83(5):751-9. PubMed ID: 21360548
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir.
Bercoff DP; Triqueneaux P; Lambert C; Oumar AA; Ternes AM; Dao S; Goubau P; Schmit JC; Ruelle J
Retrovirology; 2010 Nov; 7():98. PubMed ID: 21114823
[TBL] [Abstract][Full Text] [Related]
17. HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients.
Piralla A; Paolucci S; Gulminetti R; Comolli G; Baldanti F
Virol J; 2011 Mar; 8():149. PubMed ID: 21453487
[TBL] [Abstract][Full Text] [Related]
18. Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.
Low A; Prada N; Topper M; Vaida F; Castor D; Mohri H; Hazuda D; Muesing M; Markowitz M
Antimicrob Agents Chemother; 2009 Oct; 53(10):4275-82. PubMed ID: 19651917
[TBL] [Abstract][Full Text] [Related]
19. Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades.
Doyle T; Dunn DT; Ceccherini-Silberstein F; De Mendoza C; Garcia F; Smit E; Fearnhill E; Marcelin AG; Martinez-Picado J; Kaiser R; Geretti AM;
J Antimicrob Chemother; 2015 Nov; 70(11):3080-6. PubMed ID: 26311843
[TBL] [Abstract][Full Text] [Related]
20. HIV Type 1 Integrase Natural Polymorphisms in Viral Variants Circulating in FSU Countries.
Lapovok I; Laga V; Kazennova E; Bobkova M
Curr HIV Res; 2017 Nov; 15(5):318-326. PubMed ID: 28814231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
